Latest Anticonvulsants Stories
EXTON, Pa., June 24, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of a Pediatric Use Marketing Authorization (PUMA) for BuccolamÂ® (midazolam, oromucosal solution), for treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years.
SAN DIEGO, June 14, 2011 /PRNewswire/ -- Neurelis, Inc. today announced the results of a randomized crossover study in healthy volunteers assessing diazepam pharmacokinetics and bioavailability after administration of their proprietary intranasal diazepam formulations and intravenous injection.
A new study published by has indicated that infants exposed to antiepileptic drugs, such as Depakote, during pregnancy may have an even higher risk of developing serious birth defects.
Topiramate is a medication thatâ€™s been used for the treatment of the seizures associated with epilepsy, and in recent years it has also been used to treat the symptoms of migraine headaches.
ATLANTA, June 9, 2011 /PRNewswire/ -- UCB, Inc. today announced an agreement with the U.S. Department of Justice (DOJ) to resolve a previously disclosed government investigation into the marketing and promotion of KeppraÂ®, an anti-epileptic prescription medicine.
The drug topiramate can help people lose weight as long as they can tolerate the side effects, according to authors of a new study that reviewed the medical literature.
BALTIMORE, May 31, 2011 /PRNewswire/ -- UCB announced findings of the first cost-effectiveness analysis of VimpatÂ® (lacosamide) as add-on therapy for adults with uncontrolled partial-onset seizures.
REHOVOT, Israel, May 31, 2011 /PRNewswire-FirstCall/ -- D-Pharm Ltd. (TASE: DPRM) announced today that it has entered into a licensing and co-development agreement with Jiangsu NHWA Pharmaceutical Co., Ltd.(NHWA) to commercialize DP-VPA for epilepsy in the People's Republic of China.
Topamax, an antiepileptic and migraine medication, was analyzed in a recent European study that was designed to provide information regarding potential Topamax side effects and the potential harm that other medications could inflict on expecting mothers.
PITTSBURGH, May 23, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Divalproex Sodium Capsules USP, 125 mg, the generic version of Abbott's DepakoteÂ® Sprinkle Capsules, a treatment for certain types of seizures.
- A person in a secondary role, specifically the second most important character (after the protagonist).